NYLI Candriam Internation... (IQSI)
NYSEArca: IQSI
· Echtzeitkurs · USD
39.42
+0.00 (0.00%)
Zum Schluss: Aug 13, 2026, 9:46 AM
NYLI Candriam International Equity ETF (IQSI) ETF Price, Holdings & Analysis
0.00% (1D)
| Geld | 39.62 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 267.58 Mio |
| NAV | 39.42 |
| Beta | 0.97 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 20.69 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Dec 17, 2019 |
| Brief | 39.64 |
| Volumen | 139 |
| Ø Vol. (20D) | 21,520 |
| Eröffnung | 39.45 |
| Vortagesschluss | 39.42 |
| Tagesspanne | 39.42 - 39.42 |
| 52-Wk Range | 33.10 - 39.52 |
| Positionen | k.A. |
| Kostenquote | 0.15% |
Über IQSI
The Advisor employs a "passive management"?-?or indexing?-?investment approach designed to track the performance of the underlying index. The underlying index is designed to deliver exposure to equity securities of companies meeting environmental, social and corporate governance (ESG) criteria developed by Candriam and weighted using a market-capitalization weighting methodology.
Anlageklasse Equity
Tickersymbol IQSI
Auflagedatum Dec 17, 2019
Website Fonds-Homepage
Börse NYSEArca
Top Sektoren
| Sektor | Gewicht % |
|---|---|
| Financial Services | 23.81% |
| Industrials | 16.40% |
| Technology | 15.98% |
| Healthcare | 13.04% |
| Consumer Cyclical | 7.62% |
Top 10 Positionen 19.34% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Asml Holding Nv | ASML.AS | 4.59% |
| Roche Holding Ag Ord... | ROP.SW | 2.15% |
| Novartis Ag Register... | NOVN.SW | 2.02% |
| Nestle Sa | NESN.SW | 1.89% |
| Astrazeneca PLC | AZN.L | 1.76% |
| Siemens Ag | SIE.DE | 1.60% |
| Commonwealth Bank Of... | CBA.AX | 1.46% |
| Toyota Motor Corp | 7203.T | 1.42% |
| Schneider Electric S... | SU.PA | 1.23% |
| Sap Se | SAP.DE | 1.22% |
Dividenden Dividendenrendite 2.62%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jun 18, 2026 | $0.5750 | k.A. |
| Mar 20, 2026 | $0.0910 | k.A. |
| Dec 19, 2025 | $0.2440 | k.A. |
| Sep 19, 2025 | $0.1220 | k.A. |
| Jun 20, 2025 | $0.5010 | k.A. |